These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33990583)

  • 1. Exploring ligand binding pathways on proteins using hypersound-accelerated molecular dynamics.
    Araki M; Matsumoto S; Bekker GJ; Isaka Y; Sagae Y; Kamiya N; Okuno Y
    Nat Commun; 2021 May; 12(1):2793. PubMed ID: 33990583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerating Rare Dissociative Processes in Biomolecules Using Selectively Scaled MD Simulations.
    Deb I; Frank AT
    J Chem Theory Comput; 2019 Nov; 15(11):5817-5828. PubMed ID: 31509413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular simulation studies on the binding selectivity of 2-anilino-4-(thiazol-5-yl)-pyrimidines in complexes with CDK2 and CDK7.
    Chohan TA; Qian HY; Pan YL; Chen JZ
    Mol Biosyst; 2016 Jan; 12(1):145-61. PubMed ID: 26565382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Conformational Flexibility on Binding Free Energy Estimation between Kinases and Their Inhibitors.
    Araki M; Kamiya N; Sato M; Nakatsui M; Hirokawa T; Okuno Y
    J Chem Inf Model; 2016 Dec; 56(12):2445-2456. PubMed ID: 28024406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using metadynamics and path collective variables to study ligand binding and induced conformational transitions.
    Bešker N; Gervasio FL
    Methods Mol Biol; 2012; 819():501-13. PubMed ID: 22183554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding free energy estimation for protein-ligand complex based on MM-PBSA with various partial charge models.
    Fu T; Jin Z; Xiu Z; Li G
    Curr Pharm Des; 2013; 19(12):2293-307. PubMed ID: 23082979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modeling studies to characterize N-phenylpyrimidin-2-amine selectivity for CDK2 and CDK4 through 3D-QSAR and molecular dynamics simulations.
    Chohan TA; Chen JJ; Qian HY; Pan YL; Chen JZ
    Mol Biosyst; 2016 Apr; 12(4):1250-68. PubMed ID: 26883408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the Accuracy of Protein-Ligand Binding Mode Prediction Using a Molecular Dynamics-Based Pocket Generation Approach.
    Araki M; Iwata H; Ma B; Fujita A; Terayama K; Sagae Y; Ono F; Tsuda K; Kamiya N; Okuno Y
    J Comput Chem; 2018 Dec; 39(32):2679-2689. PubMed ID: 30515903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decoding molecular mechanism of inhibitor bindings to CDK2 using molecular dynamics simulations and binding free energy calculations.
    Chen J; Pang L; Wang W; Wang L; Zhang JZH; Zhu T
    J Biomol Struct Dyn; 2020 Mar; 38(4):985-996. PubMed ID: 30843759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Modeling and Design Studies of Purine Derivatives as Novel CDK2 Inhibitors.
    Zhang G; Ren Y
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30423939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in silico exploration of the interaction mechanism of pyrazolo[1,5-a]pyrimidine type CDK2 inhibitors.
    Li Y; Gao W; Li F; Wang J; Zhang J; Yang Y; Zhang S; Yang L
    Mol Biosyst; 2013 Sep; 9(9):2266-81. PubMed ID: 23864105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of High-Affinity Inhibitors of Cyclin-Dependent Kinase 2 Towards Anticancer Therapy.
    Mohammad T; Batra S; Dahiya R; Baig MH; Rather IA; Dong JJ; Hassan I
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31847444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing limitations with the MM-GB/SA scoring procedure using the WaterMap method and free energy perturbation calculations.
    Guimarães CR; Mathiowetz AM
    J Chem Inf Model; 2010 Apr; 50(4):547-59. PubMed ID: 20235592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extra precision docking, free energy calculation and molecular dynamics simulation studies of CDK2 inhibitors.
    Tripathi SK; Muttineni R; Singh SK
    J Theor Biol; 2013 Oct; 334():87-100. PubMed ID: 23727278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing an ensemble docking-based virtual screening strategy for kinase targets by considering protein flexibility.
    Tian S; Sun H; Pan P; Li D; Zhen X; Li Y; Hou T
    J Chem Inf Model; 2014 Oct; 54(10):2664-79. PubMed ID: 25233367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the Stability of Ligand Binding Modes to Proteins by Molecular Dynamics Simulations: A Cross-docking Study.
    Liu K; Kokubo H
    J Chem Inf Model; 2017 Oct; 57(10):2514-2522. PubMed ID: 28902511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frontiers in molecular dynamics simulations of DNA.
    Pérez A; Luque FJ; Orozco M
    Acc Chem Res; 2012 Feb; 45(2):196-205. PubMed ID: 21830782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type II Inhibitors Targeting CDK2.
    Alexander LT; Möbitz H; Drueckes P; Savitsky P; Fedorov O; Elkins JM; Deane CM; Cowan-Jacob SW; Knapp S
    ACS Chem Biol; 2015 Sep; 10(9):2116-25. PubMed ID: 26158339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accurate Prediction of Complex Structure and Affinity for a Flexible Protein Receptor and Its Inhibitor.
    Bekker GJ; Kamiya N; Araki M; Fukuda I; Okuno Y; Nakamura H
    J Chem Theory Comput; 2017 Jun; 13(6):2389-2399. PubMed ID: 28482660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A computational study of the protein-ligand interactions in CDK2 inhibitors: using quantum mechanics/molecular mechanics interaction energy as a predictor of the biological activity.
    Alzate-Morales JH; Contreras R; Soriano A; Tuñon I; Silla E
    Biophys J; 2007 Jan; 92(2):430-9. PubMed ID: 17085505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.